Until recently, many cancer sufferers have been happy to receive care on the NHS. However, the rising cost of new drugs and procedures is forcing many local authorities to limit treatment. With more than one in three people destined to receive a diagnosis in their lifetime, more people are turning to the private sector for peace of mind. But are insurers delivering the goods?
Cancer cover varies substantially across the individual private medical insurance (PMI) market. To clarify the extent and